Explore more publications!

Tech Times of New York: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Tech Times of New York.

Press releases published on January 11, 2026

Blokko and Datecs Open the Door to Stablecoin, Crypto and Global Wallet Payments at the Point of Sale
Blokko Revolutionizes Global Commerce @ NRF 2026: Merchants Accept Crypto & Stablecoins with Local-Currency Settlement
MicroTouch Unveils New Mach 15.6" Android POS System at NRF 2026
MicroTouch Showcases Next-Gen Touch Solutions and Launches Android 15 Across Its Mach Line at NRF 2026
Zymeworks Outlines Strategic Priorities and Outlook for 2026
Teva to Present at the 44th Annual J.P. Morgan Healthcare Conference: Pivot to Growth Strategy Delivering Growth and Transforming through Innovation
Royalty Pharma and Teva Enter Agreement to Accelerate Development of Potential Treatment for Vitiligo
Beam Therapeutics Sets Strategic Priorities for its Genetic Disease and Hematology Franchises to Drive Execution of Late-Stage Clinical Programs and Extends its Operating Runway through Commercial Transition
Teva and Royalty Pharma Enter Agreement to Accelerate Development of Potential Treatment for Vitiligo
Kura Oncology Highlights Recent Accomplishments, Preliminary KOMZIFTI Revenue and Anticipated 2026 Milestones
Day One Announces Preliminary 2025 OJEMDA™ Net Product Revenue And Provides 2026 Net Product Revenue Guidance
MBX Biosciences to Provide 2026 Outlook and Business Update at 44th Annual J.P. Morgan Healthcare Conference
Visual AI Takes Center Stage at CES 2026: FIRSTHABIT’s ‘Chalk 4.0’ Becomes the Silicon Valley of Eureka Park
Speediance Brings the Future of Smart Home Fitness to Life at CES 2026
Krystal Biotech Provides Business Update at 44th Annual J.P. Morgan Healthcare Conference
Bronstein, Gewirtz & Grossman LLC Urges Fermi Inc. Investors to Act: Class Action Filed Alleging Investor Harm
Bronstein, Gewirtz & Grossman LLC Urges F5, Inc. Investors to Act: Class Action Filed Alleging Investor Harm
Commerce Supports Universal Commerce Protocol, Plans to Offer Buying Directly Across Google’s AI Surfaces
Benitec Biopharma Provides Positive Long-Term Clinical Study Results for BB-301 Phase 1b/2a Clinical Trial Demonstrating Robust Efficacy and Continued Durability of Response

Share us

on your social networks:
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms & Conditions